The structural profiles are close, with Amgen carrying a narrow edge on profitability. The remaining gap is narrow enough that the comparison remains open to different readings. In the market, GSK carries the stronger setup — intact trend against Amgen's broken trend. That leaves a split case: the structural lead stays with Amgen, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (AMGN: Nasdaq 100, GSK.L: STOXX 600).
Most of the separation is still concentrated in profitability.
Both operate in: Drug Manufacturers - General
This comparison is based on industry proximity, not on functional trajectory similarity. AMGN and GSK.L share the same industry classification.
For a similarity-based comparison, see how Amgen and GSK each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in profitability.
Left means cheaper relative valuation. Higher means stronger structure.
The setup stays mixed because structure and the price setup do not align cleanly in one direction.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Return on equity adds support too, with a 60-point advantage.
Amgen Inc. also shows lower market-fundamental divergence, which makes the lead look less detached from the underlying business picture.
Profitability is the clearest driver, and stability also supports Amgen Inc.'s broader structural position.
Break down the AMGN vs GSK.L comparison across all dimensions with the full interactive tool.
Explore how AMGN and GSK.L each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.